Self-monitoring for T2DM in Canada: what do the models say?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.642, 2011-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What do our clients say? Residents' perceptions of recovery in Retorno - A Jewish therapeutic community

By Ronel Natti

Addiction Research and Theory, Vol. 21, Iss. 4, 2013-08 ,pp. : 295-305

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone a star performer in the T2DM arena?

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Can preventive screening programmes for T2DM be cost effective in Germany?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Blood glucose self monitoring not economical in T2DM

Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Blood glucose self monitoring not economical in T2DM

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 553, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite